179 related articles for article (PubMed ID: 38550998)
1. Evolvability of cancer-associated genes under APOBEC3A/B selection.
Song JH; Dávalos LM; MacCarthy T; Damaghi M
iScience; 2024 Apr; 27(4):109433. PubMed ID: 38550998
[TBL] [Abstract][Full Text] [Related]
2. Evolvability of cancer-associated genes under APOBEC3A/B selection.
Song JH; Dávalos LM; MacCarthy T; Damaghi M
bioRxiv; 2023 Dec; ():. PubMed ID: 38106028
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of APOBEC3 mutagenesis in human cancer cells.
Petljak M; Dananberg A; Chu K; Bergstrom EN; Striepen J; von Morgen P; Chen Y; Shah H; Sale JE; Alexandrov LB; Stratton MR; Maciejowski J
Nature; 2022 Jul; 607(7920):799-807. PubMed ID: 35859169
[TBL] [Abstract][Full Text] [Related]
4. Integrative genomic analyses of APOBEC-mutational signature, expression and germline deletion of APOBEC3 genes, and immunogenicity in multiple cancer types.
Chen Z; Wen W; Bao J; Kuhs KL; Cai Q; Long J; Shu XO; Zheng W; Guo X
BMC Med Genomics; 2019 Sep; 12(1):131. PubMed ID: 31533728
[TBL] [Abstract][Full Text] [Related]
5. Evolutionary potential of the monkeypox genome arising from interactions with human APOBEC3 enzymes.
Delamonica B; Davalos L; Larijani M; Anthony SJ; Liu J; MacCarthy T
Virus Evol; 2023; 9(2):vead047. PubMed ID: 37577211
[TBL] [Abstract][Full Text] [Related]
6. Involvement of APOBEC3A/B Deletion in Mouse Mammary Tumor Virus (MMTV)-like Positive Human Breast Cancer.
de Sousa Pereira N; Vitiello GAF; Amarante MK
Diagnostics (Basel); 2023 Mar; 13(6):. PubMed ID: 36980505
[TBL] [Abstract][Full Text] [Related]
7. Prospectively defined patterns of APOBEC3A mutagenesis are prevalent in human cancers.
DeWeerd RA; Németh E; Póti Á; Petryk N; Chen CL; Hyrien O; Szüts D; Green AM
Cell Rep; 2022 Mar; 38(12):110555. PubMed ID: 35320711
[TBL] [Abstract][Full Text] [Related]
8. Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer.
Carpenter MA; Temiz NA; Ibrahim MA; Jarvis MC; Brown MR; Argyris PP; Brown WL; Starrett GJ; Yee D; Harris RS
PLoS Genet; 2023 Nov; 19(11):e1011043. PubMed ID: 38033156
[TBL] [Abstract][Full Text] [Related]
9. Evolutionary potential of the monkeypox genome arising from interactions with human APOBEC3 enzymes.
Delamonica B; Davalos L; Larijani M; Anthony SJ; Liu J; MacCarthy T
bioRxiv; 2023 Jun; ():. PubMed ID: 37425914
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide mapping of regions preferentially targeted by the human DNA-cytosine deaminase APOBEC3A using uracil-DNA pulldown and sequencing.
Sakhtemani R; Senevirathne V; Stewart J; Perera MLW; Pique-Regi R; Lawrence MS; Bhagwat AS
J Biol Chem; 2019 Oct; 294(41):15037-15051. PubMed ID: 31431505
[TBL] [Abstract][Full Text] [Related]
11. Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA.
Bergstrom EN; Luebeck J; Petljak M; Khandekar A; Barnes M; Zhang T; Steele CD; Pillay N; Landi MT; Bafna V; Mischel PS; Harris RS; Alexandrov LB
Nature; 2022 Feb; 602(7897):510-517. PubMed ID: 35140399
[TBL] [Abstract][Full Text] [Related]
12. An APOBEC3 Mutational Signature in the Genomes of Human-Infecting Orthopoxviruses.
Forni D; Cagliani R; Pozzoli U; Sironi M
mSphere; 2023 Apr; 8(2):e0006223. PubMed ID: 36920219
[TBL] [Abstract][Full Text] [Related]
13. APOBEC mutational signature predicts prognosis and immunotherapy response in nonsmoking patients with lung adenocarcinoma.
Ma J; Yang X; Zhang J; Antonoff MB; Wu Q; Ji H
Transl Lung Cancer Res; 2023 Mar; 12(3):580-593. PubMed ID: 37057114
[TBL] [Abstract][Full Text] [Related]
14. The 30 kb deletion in the
Klonowska K; Kluzniak W; Rusak B; Jakubowska A; Ratajska M; Krawczynska N; Vasilevska D; Czubak K; Wojciechowska M; Cybulski C; Lubinski J; Kozlowski P
Oncotarget; 2017 Sep; 8(44):76357-76374. PubMed ID: 29100317
[No Abstract] [Full Text] [Related]
15. The rabbit as an orthologous small animal model for APOBEC3A oncogenesis.
Laude HC; Caval V; Bouzidi MS; Li X; Jamet F; Henry M; Suspène R; Wain-Hobson S; Vartanian JP
Oncotarget; 2018 Jun; 9(45):27809-27822. PubMed ID: 29963239
[TBL] [Abstract][Full Text] [Related]
16. Addressing the benefits of inhibiting APOBEC3-dependent mutagenesis in cancer.
Petljak M; Green AM; Maciejowski J; Weitzman MD
Nat Genet; 2022 Nov; 54(11):1599-1608. PubMed ID: 36280735
[TBL] [Abstract][Full Text] [Related]
17. Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection.
Kim EY; Lorenzo-Redondo R; Little SJ; Chung YS; Phalora PK; Maljkovic Berry I; Archer J; Penugonda S; Fischer W; Richman DD; Bhattacharya T; Malim MH; Wolinsky SM
PLoS Pathog; 2014 Jul; 10(7):e1004281. PubMed ID: 25080100
[TBL] [Abstract][Full Text] [Related]
18. Footprint of the host restriction factors APOBEC3 on the genome of human viruses.
Poulain F; Lejeune N; Willemart K; Gillet NA
PLoS Pathog; 2020 Aug; 16(8):e1008718. PubMed ID: 32797103
[TBL] [Abstract][Full Text] [Related]
19. The interesting relationship between APOBEC3 deoxycytidine deaminases and cancer: a long road ahead.
Granadillo Rodríguez M; Flath B; Chelico L
Open Biol; 2020 Dec; 10(12):200188. PubMed ID: 33292100
[TBL] [Abstract][Full Text] [Related]
20. Elucidation of the Complicated Scenario of Primate APOBEC3 Gene Evolution.
Uriu K; Kosugi Y; Suzuki N; Ito J; Sato K
J Virol; 2021 May; 95(12):. PubMed ID: 33789992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
